RSPH: Invesco S&P 500 Equal Weight Health Care ETF
About
RSPH was created on 2006-11-01 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 900.75m in AUM and 63 holdings. RSPH tracks an equal-weighted index of US health care companies taken from the S&P 500 Index.
Current Value
$30.611 Year Return
Current Value
$30.611 Year Return
Key Details
Assets Under Management
$879.32M
Div Yield %
0.66%
P/E Ratio
24.88
Net Asset Value
$30.60
Expense Ratio
0.40%
1Y ETF Return
0.11%
Strategies that include RSPH
Stock's related to RSPH
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -31.03% | $18.58M | -19.77% | 0.00% |
| TPST | -11.79% | $39.00M | -78.67% | 0.00% |
| PULM | -10.40% | $22.32M | +230.27% | 0.00% |
| MNR | -9.83% | $1.70B | -6.89% | 15.55% |
| TCTM | -8.57% | $7.57M | -41.30% | 0.00% |
| QTTB | -6.60% | $329.37M | +172.64% | 0.00% |
| LPTH | -5.92% | $59.50M | +22.95% | 0.00% |
| LTM | -3.54% | $8.37B | -100.00% | <0.01% |
| CBOE | -3.44% | $22.09B | +17.17% | 1.08% |
| FATBB | -2.80% | $75.27M | -12.35% | 12.73% |
| NNE | -1.56% | $965.35M | +631.25% | 0.00% |
| STG | -1.28% | $35.47M | +5.43% | 0.00% |
| CORZ | -1.16% | $4.90B | +3,634.04% | 0.00% |
| NHTC | -1.04% | $64.47M | +3.99% | 13.82% |
| BTCT | -0.84% | $58.86M | +395.83% | 0.00% |
| OXBR | -0.52% | $19.24M | +183.49% | 0.00% |
| PRPO | -0.33% | $8.89M | -14.59% | 0.00% |
| INSM | -0.10% | $13.20B | +211.04% | 0.00% |
| PGR | 0.26% | $154.33B | +62.01% | 0.44% |
| UUU | 0.48% | $4.98M | -18.37% | 0.00% |
ETF's related to RSPH
News
SeekingAlpha
While the drop has resulted in extreme underperformance versus the S&P 500, it has also resulted in the sector's weight in the S&P 500 falling dramatically.
SeekingAlpha
November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced.
SeekingAlpha
The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.
SeekingAlpha
Healthcare companies often grab headlines for their drug innovations. But itâs notoriously difficult to handicap outcomes, and we think investors' focus should be on business fundamentals.
SeekingAlpha
Trade and investment, tax, immigration, and fiscal policies, and his approach to the Fed may impact some investments. Read more here.
SeekingAlpha
Since the Federal Open Market Committee lowered rates in September, Treasury yields have moved in the opposite direction across both the long and short ends of the yield curve.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.